TrialBMC nephrology2022

Efficacy and safety of a low-sodium diet and spironolactone in patients with stage 1-3a chronic kidney disease: a pilot study.

Hongmei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.